Journal Information

Clinical areas: Oncology

Influence of the UGT1A1 gene polymorphism on treatment with sacituzumab govitecan. Narrative review
Eva María Legido Perdices, Fernando do Pazo Oubiña, Elena Prado Mel, Marta Miarons, Betel Del Rosario García, Fernando Gutiérrez Nicolás
Farm Hosp. 2025;49:T339-T345
Full text access
Vemurafenib for the treatment of BRAF V600 mutated glioblastoma: A case report
Irene de la Fuente Villaverde, Alicia Caso González, Mónica Carbajales Álvarez, Alba Martínez Torrón, Sergio Fernández Lastras, Juan Luis García Llano, Ana Lozano Blázquez
Farm Hosp. 2025;49:T346-T348
Full text access
Messenger RNA as a new strategy against cancer
Eduardo Tejedor Tejada, Begoña Gómez Pérez, Garbiñe Lizeaga Cundin
Farm Hosp. 2025;49:T350
Full text access
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes
Héctor Carlos García-Díaz, María Larrosa-Garcia, Javier Gómez-Alonso, Mara Cruellas, Enriqueta Felip, Teresa Macarulla, Anna Farriols, Maria J. Carreras
Farm Hosp. 2025;49:286-90
Full text access
Relationship between lactate dehydrogenase and survival in patients with non-small-cell lung cancer receiving immunotherapy
Claudia Rosique-Aznar, Alejandro Valcuende-Rosique, Dolores Rosique-Robles, Agustín Sánchez-Alcaraz
Farm Hosp. 2025;49:T143-T147
Full text access
Toxicity of the FOLFOX-6 regimen, with or without 5-fluorouracil bolus, in metastatic colorectal cancer
María Teresa Garrido Martínez, María Rodríguez Jorge, Ignacio García Giménez, María Isabel Guzmán Ramos, Salvador Grutzmancher Sáiz, Victoria Aviñó Tarazona
Farm Hosp. 2025;49:T154-T159
Full text access
Treatment adherence to oral chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer: Protocol for a hospital pharmacy-based real-world study
Irene Mangues-Bafalluy, Beatriz Bernárdez, José Manuel Martínez-Sesmero, Andres Navarro-Ruiz, Ana Rosa Rubio-Salvador, Maria Teresa Martín-Conde
Farm Hosp. 2025;49:117-21
Full text access
Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population
Cristina Galindo García, Rocío Díaz Acedo, Silvia Artacho Criado, María Rodríguez de la Borbolla Artacho
Farm Hosp. 2024;48:278-85
Full text access
Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms
Beatriz Bernardez, Irene Mangues-Bafalluy, Virginia Martínez Callejo, Juan José Fernández Ávila, Jose Antonio Marcos Rodríguez, Maria Angeles Parada Aradilla, María José Martínez Bautista
Farm Hosp. 2024;48:108-15
Full text access
Abemaciclib as adjuvant treatment for high-risk early breast cancer
Ana Ganfornina Andrades, Silvia Fénix Caballero, Alba Salguero Olid, Jesús Alegre Del-Rey Emilio
Farm Hosp. 2024;48:75-8
Full text access
Genetic variants and enzyme activity in citidin deaminase: Relationship with capecitabine toxicity and recommendation for dose adjustment
Paula Castro-Sánchez, Mª. Amparo Talens-Bolós, María José Prieto-Castelló, Loreto Pitaluga-Poveda, Juan Antonio Barrera-Ramírez, Andrés Corno-Caparrós
Farm Hosp. 2023;47:T127-T132
Full text access
Design and validation of a scale to measure adherence to oral antineoplastic drugs
Amparo Talens-Bolós, Elsa López-Pintor, Mercedes Guilabert-Mora, Teresa Aznar-Saliente, Domingo L. Orozco-Beltrán, Blanca Lumbreras-Lacarra
Farm Hosp. 2023;47:T80-T84
Full text access
Idiomas
Farmacia Hospitalaria